Target Delivery of Anti-tumour Therapeutics for Improved Cancer Treatment
Duration:
January 2020–July 2025
Project Summary
This project uses the CaP-lipid-based nanoparticle to deliver therapeutic agents (such as siRNAs, growth factors, cytokines, and/or drugs) to target cells, tumours or tumour microenvironment, leading to the regression or even the elimination of solid tumours.
Research Group
Keywords
Nanomaterials, Nanobiotechnology, Health, Target delivery, Tumour, Nanoparticle, Tumor Microenvironment, RNAi, Cytokines, Anti-tumour Therapeutics
Available Student Projects
CaP nanoparticle-based encapsulated system for target drug delivery
